Florida AG launches investigation into CVS Health over pharmacy competition concerns
- AIPC Rx
- 1 day ago
- 1 min read
Florida Attorney General James Uthmeier issued a Civil Investigative Demand to CVS Health Corporation, the owner of the Caremark pharmacy benefit manager and hundreds of CVS retail pharmacies across the state, raising questions about whether the company has used its market position to undercut competitors and limit patient choice.
What is a Civil Investigative Demand?
A Civil Investigative Demand, or CID, is a legal tool that compels a company to produce documents and sworn testimony as part of a government investigation. The demand requires CVS Health to turn over thousands of documents by July 28, 2026, covering reimbursement rates, pharmacy contracts, patient steering, audits, rebates and expansion plans.
Why CVS Health is under scrutiny
Pharmacy Benefit Managers, commonly known as PBMs, control which drugs are covered by insurance, how much pharmacies are paid and where patients fill prescriptions. The three largest PBMs — including Caremark — handle about 80% of U.S. prescriptions.
CVS Health’s dual role as both a dominant PBM operator and a major pharmacy chain — with more than 9,000 locations nationwide, including roughly 800 in Florida — has raised concerns about self-preferencing and vertical integration.
The probe examines whether CVS/Caremark steers patients to its own retail locations, reimburses its affiliated stores more generously than independent pharmacies for identical prescriptions, imposes burdensome audits that claw back payments and enforces restrictive contracts that threaten small, independent pharmacies... Continue Reading
Comments